WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $5.3 million in its third quarter.
The Washington-based company said it had a loss of 9 cents per share.
The biopharmaceutical company posted revenue of $47.7 million in the period.
Vanda expects full-year revenue in the range of $190 million to $210 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA
